Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03088059
Title Biomarker-based Study in R/M SCCHN (UPSTREAM)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors European Organisation for Research and Treatment of Cancer - EORTC
Indications

head and neck squamous cell carcinoma

Therapies

Niraparib

Durvalumab + Monalizumab

Methotrexate

Carboplatin

Rogaratinib

Mitomycin C

Docetaxel

Afatinib

Paclitaxel

Durvalumab

Monalizumab

Palbociclib

Bleomycin

Gemcitabine

Fluorouracil

Age Groups: senior | adult
Covered Countries ITA | FRA | BEL

Additional content available in CKB BOOST